Literature DB >> 19542286

igr Genes and Mycobacterium tuberculosis cholesterol metabolism.

Jennifer C Chang1, Maurine D Miner, Amit K Pandey, Wendy P Gill, Nada S Harik, Christopher M Sassetti, David R Sherman.   

Abstract

Recently, cholesterol was identified as a physiologically important nutrient for Mycobacterium tuberculosis survival in chronically infected mice. However, it remained unclear precisely when cholesterol is available to the bacterium and what additional bacterial functions are required for its metabolism. Here, we show that the igr locus, which we previously found to be essential for intracellular growth and virulence of M. tuberculosis, is required for cholesterol metabolism. While igr-deficient strains grow identically to the wild type in the presence of short- and long-chain fatty acids, the growth of these bacteria is completely inhibited in the presence of cholesterol. Interestingly, this mutant is still able to respire under cholesterol-dependent growth inhibition, suggesting that the bacteria can metabolize other carbon sources during cholesterol toxicity. Consistent with this hypothesis, we found that the growth-inhibitory effect of cholesterol in vitro depends on cholesterol import, as mutation of the mce4 sterol uptake system partially suppresses this effect. In addition, the Delta igr mutant growth defect during the early phase of disease is completely suppressed by mutating mce4, implicating cholesterol intoxication as the primary mechanism of attenuation. We conclude that M. tuberculosis metabolizes cholesterol throughout infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542286      PMCID: PMC2725594          DOI: 10.1128/JB.00452-09

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  Essential role for cholesterol in entry of mycobacteria into macrophages.

Authors:  J Gatfield; J Pieters
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

2.  Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro.

Authors:  H BLOCH; W SEGAL
Journal:  J Bacteriol       Date:  1956-08       Impact factor: 3.490

3.  Accumulation of cholesterol esters in macrophages incubated with mycobacteria in vitro.

Authors:  E Kondo; K Kanai
Journal:  Jpn J Med Sci Biol       Date:  1976-06

4.  Steroid degradation gene cluster of Comamonas testosteroni consisting of 18 putative genes from meta-cleavage enzyme gene tesB to regulator gene tesR.

Authors:  Masae Horinouchi; Tomokazu Kurita; Takako Yamamoto; Emi Hatori; Toshiaki Hayashi; Toshiaki Kudo
Journal:  Biochem Biophys Res Commun       Date:  2004-11-12       Impact factor: 3.575

5.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

6.  Genes required for mycobacterial growth defined by high density mutagenesis.

Authors:  Christopher M Sassetti; Dana H Boyd; Eric J Rubin
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

7.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

8.  Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.

Authors:  D M Yajko; J J Madej; M V Lancaster; C A Sanders; V L Cawthon; B Gee; A Babst; W K Hadley
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

9.  Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Katherine C Yam; Igor D'Angelo; Rainer Kalscheuer; Haizhong Zhu; Jian-Xin Wang; Victor Snieckus; Lan H Ly; Paul J Converse; William R Jacobs; Natalie Strynadka; Lindsay D Eltis
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

10.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.

Authors:  Dirk Schnappinger; Sabine Ehrt; Martin I Voskuil; Yang Liu; Joseph A Mangan; Irene M Monahan; Gregory Dolganov; Brad Efron; Philip D Butcher; Carl Nathan; Gary K Schoolnik
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

View more
  72 in total

1.  Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Authors:  Suzanne T Thomas; Brian C VanderVen; David R Sherman; David G Russell; Nicole S Sampson
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

2.  Mycobacterium tuberculosis cholesterol catabolism requires a new class of acyl coenzyme A dehydrogenase.

Authors:  Martin I Voskuil
Journal:  J Bacteriol       Date:  2013-07-26       Impact factor: 3.490

3.  The mycobacterial P55 efflux pump is required for optimal growth on cholesterol.

Authors:  Santiago Ramón-García; Gordon R Stewart; Zhao Kun Hui; William W Mohn; Charles J Thompson
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 4.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

5.  Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations.

Authors:  Jennifer E Griffin; Amit K Pandey; Sarah A Gilmore; Valerie Mizrahi; John D McKinney; Carolyn R Bertozzi; Christopher M Sassetti
Journal:  Chem Biol       Date:  2012-02-24

Review 6.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

7.  FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis.

Authors:  Christin M Schaefer; Rui Lu; Natasha M Nesbitt; Johannes Schiebel; Nicole S Sampson; Caroline Kisker
Journal:  Structure       Date:  2014-12-04       Impact factor: 5.006

8.  Deciphering the transcriptional regulation of cholesterol catabolic pathway in mycobacteria: identification of the inducer of KstR repressor.

Authors:  Esther García-Fernández; Francisco Javier Medrano; Beatriz Galán; José Luis García
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

9.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

10.  A highly conserved mycobacterial cholesterol catabolic pathway.

Authors:  Esther García-Fernández; Daniel J Frank; Beatriz Galán; Petrea M Kells; Larissa M Podust; José L García; Paul R Ortiz de Montellano
Journal:  Environ Microbiol       Date:  2013-03-14       Impact factor: 5.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.